Cargando…

Efficacy and safety of sitagliptin treatment in older adults with moderately controlled type 2 diabetes: the STREAM study

Sitagliptin has been suggested as a treatment option for older adults with type 2 diabetes (T2D). However, no randomized controlled trial has been performed to evaluate the efficacy and safety of sitagliptin treatment in older Japanese patients with T2D. The STREAM study was a multicenter, open-labe...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nagao, Mototsugu, Sasaki, Jun, Sugihara, Hitoshi, Tanimura-Inagaki, Kyoko, Harada, Taro, Sakuma, Ichiro, Oikawa, Shinichi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9813363/ https://www.ncbi.nlm.nih.gov/pubmed/36599895 http://dx.doi.org/10.1038/s41598-022-27301-9

Ejemplares similares

Fasting plasma glucose level-based formula for estimating starting daily dose in basal-bolus insulin therapy
por: Nagao, Mototsugu, et al.
Publicado: (2023)

Frequency of Achilles Tendon Xanthoma in Patients with Acute Coronary Syndrome
por: Harada, Taro, et al.
Publicado: (2017)

Comparison of three α‐glucosidase inhibitors for glycemic control and bodyweight reduction in Japanese patients with obese type 2 diabetes
por: Sugihara, Hitoshi, et al.
Publicado: (2013)

Selective breeding of mice for different susceptibilities to high fat diet‐induced glucose intolerance: Development of two novel mouse lines, Selectively bred Diet‐induced Glucose intolerance‐Prone and ‐Resistant
por: Nagao, Mototsugu, et al.
Publicado: (2012)

SAT-456 Reduced Cholesterol Absorption and Synthesis Markers in Patients with Hyperthyroidism Due to Graves’ Disease
por: Nagamine, Tomoko, et al.
Publicado: (2020)

Association of glycated albumin with the presence of carotid plaque in patients with type 2 diabetes
por: Sato, Yuki, et al.
Publicado: (2013)

Perioperative glycemic status is linked to postoperative complications in non-intensive care unit patients with type-2 diabetes: a retrospective study
por: Oba, Takeshi, et al.
Publicado: (2022)

Repetitive Glucose Spikes Accelerate Atherosclerotic Lesion Formation in C57BL/6 Mice
por: Shuto, Yuki, et al.
Publicado: (2015)

Multiple daily insulin injections ameliorate QT interval by lowering blood glucose levels in patients with type 2 diabetes
por: Kobayashi, Shunsuke, et al.
Publicado: (2021)

MON-LB112 Socioeconomic Status, Literacy, and Sex Differences in the Progression of Retinopathy in Patients With Type 2 Diabetes in Tokyo, Japan
por: Emoto, Naoya, et al.
Publicado: (2020)

Severity and multiplicity of microvascular complications are associated with QT interval prolongation in patients with type 2 diabetes
por: Kobayashi, Shunsuke, et al.
Publicado: (2017)

Different pathogenesis of glucose intolerance in two subtypes of primary aldosteronism: Aldosterone‐producing adenoma and idiopathic hyperaldosteronism
por: Okazaki‐Hada, Mikiko, et al.
Publicado: (2020)

Irrational Responses to Risk Preference Questionnaires by Patients with Diabetes with or without Retinopathy and Comparison with Those without Diabetes
por: Emoto, Naoya, et al.
Publicado: (2020)

Metformin Attenuates Early-Stage Atherosclerosis in Mildly Hyperglycemic Oikawa-Nagao Mice
por: Asai, Akira, et al.
Publicado: (2019)

Postprandial Increase in Energy Expenditure Correlates with Body Weight Reduction in Patients with Type 2 Diabetes Receiving Diet Therapy
por: Sanoyama, Daisuke, et al.
Publicado: (2017)

Insulin and heparin challenge tests are useful for choosing an optimal insulin regimen in a case of subcutaneous insulin resistance
por: Nakamura, Yuko, et al.
Publicado: (2020)

FoxO1 breaks diabetic heart
por: Nagao, Mototsugu, et al.
Publicado: (2013)

Characterization of Pancreatic Islets in Two Selectively Bred Mouse Lines with Different Susceptibilities to High-Fat Diet-Induced Glucose Intolerance
por: Nagao, Mototsugu, et al.
Publicado: (2014)

Potential Protection Against Type 2 Diabetes in Obesity Through Lower CD36 Expression and Improved Exocytosis in β-Cells
por: Nagao, Mototsugu, et al.
Publicado: (2020)

Prenatal Nicotine Exposure Induces Low Birthweight and Hyperinsulinemia in Male Rats
por: Nemoto, Takahiro, et al.
Publicado: (2021)

Efficacy and Safety of Sitagliptin Versus Glipizide in Patients With Type 2 Diabetes and Moderate-to-Severe Chronic Renal Insufficiency
por: Arjona Ferreira, Juan Camilo, et al.
Publicado: (2013)

Pancreatic Safety of Sitagliptin in the TECOS Study
por: Buse, John B., et al.
Publicado: (2017)

Efficacy and safety of ipragliflozin in Japanese patients with type 2 diabetes and inadequate glycaemic control on sitagliptin
por: Kaku, Kohei, et al.
Publicado: (2021)

Efficacy and Safety of Sitagliptin in Japanese Patients With Type 2 Diabetes
por: Ohmura, Hirotoshi, et al.
Publicado: (2015)

Efficacy of Combination Therapy With Sitagliptin and Low-Dose Glimepiride in Japanese Patients With Type 2 Diabetes
por: Ishii, Hiroaki, et al.
Publicado: (2014)

Sitagliptin, sitagliptin and metformin, or sitagliptin and amitriptyline attenuate streptozotocin-nicotinamide induced diabetic neuropathy in rats
por: Sharma, Ashish Kumar, et al.
Publicado: (2012)

Efficacy and Safety of Sitagliptin for the Treatment of New-Onset Diabetes after Renal Transplantation
por: Boerner, Brian P., et al.
Publicado: (2014)

Efficacy and safety of sitagliptin for the treatment of diabetes mellitus complicated by chronic liver injury
por: Asakawa, Masahiro, et al.
Publicado: (2015)

A review of sitagliptin with special emphasis on its use in moderate to severe renal impairment
por: Eligar, Vinay S, et al.
Publicado: (2013)

Efficacy and safety of sitagliptin in Japanese patients with type 2 diabetes switched from glinides
por: Tanaka, Tsuyoshi, et al.
Publicado: (2013)

Safety and Efficacy of Sitagliptin-Metformin in Fixed Combination for the Treatment of Type 2 Diabetes Mellitus
por: Ballav, Chitrabhanu, et al.
Publicado: (2013)

Efficacy and safety of sitagliptin monotherapy and combination therapy in Japanese type 2 diabetes patients
por: Kubota, Akira, et al.
Publicado: (2012)

Sitagliptin-induced hemolysis
por: Bekur, Ragini, et al.
Publicado: (2010)

Sitagliptin-Associated Angioedema
por: Gosmanov, Aidar R., et al.
Publicado: (2012)

Efficacy and Safety of Long-term Coadministration of Fenofibrate and Ezetimibe in Patients with Combined Hyperlipidemia: Results of the EFECTL Study
por: Oikawa, Shinichi, et al.
Publicado: (2017)

A randomized, placebo‐controlled trial to assess the efficacy and safety of sitagliptin in Japanese patients with type 2 diabetes and inadequate glycaemic control on ipragliflozin
por: Seino, Yutaka, et al.
Publicado: (2021)

Efficacy and safety of sitagliptin as compared with glimepiride in Japanese patients with type 2 diabetes mellitus aged ≥ 60 years (START‐J trial)
por: Terauchi, Yasuo, et al.
Publicado: (2017)

Postprandial and Orthostatic Hypotension Treated by Sitagliptin in a Patient with Dementia with Lewy Bodies
por: Saito, Yoshihiro, et al.
Publicado: (2016)

Dipeptidyl Peptidase-4 Inhibitor Sitagliptin Phosphate Accelerates Cellular Cholesterol Efflux in THP-1 Cells
por: Komatsu, Tomohiro, et al.
Publicado: (2023)

Retrospective Analysis on the Efficacy, Safety and Treatment Failure Group of Sitagliptin for Mean 10-Month Duration
por: Kim, Won Jun, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_hjfuiktfu5q898v5jsqnv4p589